Cathie Wood’s 2022 Portfolio: 5 Small-Cap Stock Picks
In this article, we discuss the 5 small-cap stock picks of Cathie Wood's 2022 portfolio.
Fate Therapeutics Inc (FATE)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 12,957,222 | $502,351 | 15.68% | |
| 2. | ARK Investment Management Catherine D. Wood | 10,988,182 | $426,012 | +7% | 1.77% |
| 3. | Casdin Capital Eli Casdin | 3,400,000 | $131,818 | 5.91% | |
| 4. | Deep Track Capital David Kroin | 2,000,000 | $77,540 | +379% | 4.97% |
| 5. | DAFNA Capital Management Nathan Fischel | 500,930 | $19,421 | +35% | 5.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $85.50 | 327,485 | Large Shareholder, Director | 12,957,222 | 2021-01-08 | Filing | |
| $28.31 | 1,412,928 | Large Shareholder, Director | 12,629,737 | 2020-06-11 | Filing | |
| $17.50 | 857,143 | Large Shareholder, Director | 11,216,809 | 2019-09-16 | Filing | |
| $13.50 | 3,703,704 | Large Shareholder, Director | 10,359,666 | 2018-09-25 | Filing | |
| $2.66 | 37,593 | Officer | 37,593 | 2016-11-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.15 | 838 | Officer, Director | 431,546 | 2022-04-22 | Filing | |
| $34.54 | 9,162 | Officer, Director | 432,384 | 2022-04-22 | Filing | |
| $37.90 | 1,003 | Officer, Director | 431,546 | 2022-04-21 | Filing | |
| $36.70 | 2,220 | Officer, Director | 432,549 | 2022-04-21 | Filing | |
| $35.73 | 4,062 | Officer, Director | 434,769 | 2022-04-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 444,050 | $17,215,818 | 0% | |
| 2. | 43,525 | $1,687,464 | 0% | |
| 3. | 7,691,172 | $298,187 | 0% | |
| 4. | 7,105,671 | $275,487 | 0% | |
| 5. | 4,911,367 | $190,414 | 0.01% |
News See All
Top 10 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying
In this article we present the list of Top 10 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying.
Top 5 Biotech Stocks to Buy According to Jeremy Green’s Redmile Group
In this article, we discuss the top 5 biotech stocks to buy according to Jeremy Green's Redmile Group.
Was The Smart Money Right About Fate Therapeutics Inc (FATE)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Cashing Out Of Fate Therapeutics Inc (FATE)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Cathie Wood is Buying These 5 Stocks
Pacific Biosciences of California, Inc. (NASDAQ:PACB) manufactures genomic sequencing systems.
Hedge Funds Are Crazy About Fate Therapeutics Inc (FATE)
We at Insider Monkey have gone over 873 13F filings that hedge funds and prominent investors are required to file by the SEC.
Hedge Funds Have Never Been This Bullish On Fate Therapeutics Inc (FATE)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood.
Is Fate Therapeutics Stock A Buy or Sell?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December...
Billionaire Hedge Funds
